According to a new report, published by KBV research, The Global Cord Blood Banking Services Market size is expected to reach $2.9 billion by 2028, rising at a market growth of 13.1% CAGR during the forecast period.
The Cord Blood market is exhibiting a CAGR of 13.9% during (2022 - 2028). In order to treat sickle cell anemia, immunological deficiencies, metabolic problems, and blood disorders, cord blood is used in transplant surgeries. The cord blood banking services market will increase over the forecast period due to the wide-ranging applications of cord blood, a limited number of cord blood donors, and awareness by top major industry participants.
The Private Cord Blood Banks market acquired the maximum revenue share in the Global Cord Blood Banking Services Market by Storage Services in 2021; thereby, achieving a market value of $1.9 billion by 2028. This is due to the increased likelihood of finding a compatible match for the patient's blood in combination with the risk of the blood unit held in private bank not being usable.
The Cancer Disease market is showcasing a CAGR of 13.4% during (2022 - 2028). Cord blood cells are excellent in battling cancer. The term "graft-versus-leukemia effect" refers to this capability. It may aid in preventing a patient's cancer from coming back after a transplant. Stem cells that can generate blood are abundant in cord blood.
The North America market dominated the Global Cord Blood Banking Services Market by Region in 2021; thereby, achieving a market value of $1.0 billion by 2028. The Europe market is anticipated to grow at a CAGR of 12.4% during (2022 - 2028). Additionally, The Asia Pacific market would witness a CAGR of 14% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/cord-blood-banking-services-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of AMAG Pharmaceuticals, Inc., Americord Registry LLC, StemCyte, Inc., Cordlife Group Limited, cordvida, Cryo-Cell International, Inc., CryoHoldco de LatinoAmérica and Vita 34 AG
By Component
By Storage Services
By Application
By Geography
Companies Profiled
Unique Offerings 
